A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): A structured summary of a study protocol for a randomized controlled trial
- Rodríguez-Rubio, M.
- Figueira, J.C.
- Acuña-Castroviejo, D.
- Borobia, A.M.
- Escames, G.
- De La Oliva, P.
Journal:
Trials
ISSN: 1745-6215
Year of publication: 2020
Volume: 21
Issue: 1
Type: Article